ArticleQuantitative imaging in medicine and surgery2024
Semisupervised 3D segmentation of pancreatic tumors in positron emission tomography/computed tomography images using a mutual information minimization and cross-fusion strategy.
Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.
- Diagnosis methods for pancreatic cancer with the technique of deep learning: a review and a meta-analysis.Frontiers in oncology · 2025Pooled it
- A machine learning-based risk prediction model for diabetic oral ulceration.BMC oral health · 2025Article
- Artificial Intelligence in Pancreatic Image Analysis: A Review.Sensors (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate segmentation of pancreatic cancer tumors using positron emission tomography/computed tomography (PET/CT) multimodal images is crucial for clinical diagnosis and prognosis evaluation. However, deep learning methods for automated medical image segmentation require a substantial amount of manually labeled data, making it time-consuming and labor-intensive. Moreover, addition or simple stitching of multimodal images leads to redundant information, failing to fully exploit the complementary information of multimodal images. Therefore, we developed a semisupervised multimodal network that leverages limited labeled samples and introduces a cross-fusion and mutual information minimization (MIM) strategy for PET/CT 3D segmentation of pancreatic tumors. Methods: Our approach combined a cross multimodal fusion (CMF) module with a cross-attention mechanism. The complementary multimodal features were fused to form a multifeature set to enhance the effectiveness of feature extraction while preserving specific features of each modal image. In addition, we designed an MIM module to mitigate redundant high-level modal information and compute the latent loss of PET and CT. Finally, our method employed the uncertainty-aware mean teacher semi-supervised framework to segment regions of interest from PET/CT images using a small amount of labeled data and a large amount of unlabeled data. Results: We evaluated our combined MIM and CMF semisupervised segmentation network (MIM-CMFNet) on a private dataset of pancreatic cancer, yielding an average Dice coefficient of 73.14%, an average Jaccard index score of 60.56%, and an average 95% Hausdorff distance (95HD) of 6.30 mm. In addition, to verify the broad applicability of our method, we used a public dataset of head and neck cancer, yielding an average Dice coefficient of 68.71%, an average Jaccard index score of 57.72%, and an average 95HD of 7.88 mm. Conclusions: The experimental results demonstrate the superiority of our MIM-CMFNet over existing semisupervised techniques. Our approach can achieve a performance similar to that of fully supervised segmentation methods while significantly reducing the data annotation cost by 80%, suggesting it is highly practicable for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.